Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry

被引：0
|
作者：
Anna Sundlöv
Katarina Sjögreen-Gleisner
Johanna Svensson
Michael Ljungberg
Tomas Olsson
Peter Bernhardt
Jan Tennvall
机构：
[1] Lund University,Department of Oncology and Pathology, Clinical Sciences
[2] Skåne University Hospital,Department of Oncology
[3] Lund University,Department of Medical Radiation Physics, Clinical Sciences
[4] Sahlgrenska University Hospital,Department of Oncology
[5] University of Gothenburg,Department of Radiation Physics
[6] Sahlgrenska University Hospital,Department of Medical Physics and Biomedical Engineering
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2017年 / 44卷
关键词：
Lu-DOTATATE; Neuroendocrine; Dosimetry; PRRT; Renal function;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1480 / 1489
页数：9
相关论文
共 50 条
  • [1] Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
    Sundlov, Anna
    Sjogreen-Gleisner, Katarina
    Svensson, Johanna
    Ljungberg, Michael
    Olsson, Tomas
    Bernhardt, Peter
    Tennvall, Jan
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) : 1480 - 1489
  • [2] 177Lu-Dotatate for midgut neuroendocrine tumours
    Burki, Talha Khan
    [J]. LANCET ONCOLOGY, 2017, 18 (02): : E74 - E74
  • [3] 177Lu-DOTATATE Quantification for Patient Personalised Dosimetry in Therapy of Neuroendocrine Tumours
    Rodrigues, C.
    Ferreira, P.
    Oliveira, F. P. M.
    Silva, A.
    Peralta, L.
    Costa, D. C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S656 - S656
  • [4] 177Lu-DOTATATE treatment in neuroendocrine tumours. A preliminary study
    Hervas, I.
    Bello, P.
    Falgas, M.
    del Olmo, M. I.
    Torres, I.
    Olivas, C.
    Vera, V.
    Olivan, P.
    Yepes, A. M.
    [J]. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 91 - 98
  • [5] Receptor radionuclide therapy with 177Lu-DOTATATE in neuroendocrine tumours
    Bodei, L.
    Cremonesi, M.
    Grana, C.
    Bartolomei, M.
    Baio, S.
    Bufi, G.
    Fiorenza, M.
    Obenaus, E.
    Paganelli, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S214 - S214
  • [6] Individualized dosimetry in patients with metastatic neuroendocrine tumours after treatment with 177Lu-Dotatate targeted radionuclide therapy
    Kalogianni, E.
    Dunlop, A.
    Corcoran, B.
    Hooker, C.
    Devlin, L.
    Mulholland, N.
    Vivian, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S308 - S308
  • [7] Method dependence, observer variability and kidney volumes in radiation dosimetry of 177Lu-DOTATATE therapy in patients with neuroendocrine tumours
    Sandström M.
    Ilan E.
    Karlberg A.
    Johansson S.
    Freedman N.
    Garske-Román U.
    [J]. EJNMMI Physics, 2 (1) : 1 - 13
  • [8] 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors
    Das, Satya
    Al-Toubah, Taymeyah
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 13 (11) : 1023 - 1031
  • [9] Prognostic stratification for patients with neuroendocrine tumours receiving 177Lu-Dotatate
    Chen, Luohai
    Gnanasegaran, Gopinath
    Mandair, Dalvinder
    Toumpanakis, Christos
    Caplin, Martyn
    Navalkissoor, Shaunak
    [J]. ENDOCRINE-RELATED CANCER, 2022, 29 (02) : 111 - 120
  • [10] 177Lu-Dotatate for Midgut Neuroendocrine Tumors
    Matuchansky, Claude
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (14): : 1391 - 1391
12345